 | • レポートコード：MRC309Z7588 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の腫瘍多重遺伝子検出キットの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の腫瘍多重遺伝子検出キット市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 腫瘍多重遺伝子検出キットの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 腫瘍多重遺伝子検出キット市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・可逆的終端シーケンス、半導体シーケンス、複合プローブアンカー重合シーケンス 用途別セグメント ・コンパニオン診断、早期がん検診、創薬、その他 主要な市場プレーヤー ・Roche Foundation Medicine、Illumina Inc.、Life Technologies Corporation、Thermo Fisher Scientific、Memorial Sloan Kettering、Novogene、Geneseeq、AmoyDx、Burning Rock Medicine、NantHealth、Personal Genome Diagnostics、GTH.O 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、腫瘍多重遺伝子検出キット製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な腫瘍多重遺伝子検出キットメーカーの企業概要、2019年～2022年までの腫瘍多重遺伝子検出キットの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な腫瘍多重遺伝子検出キットメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別腫瘍多重遺伝子検出キットの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの腫瘍多重遺伝子検出キットの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での腫瘍多重遺伝子検出キット市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および腫瘍多重遺伝子検出キットの産業チェーンを掲載しています。 ・第14、15章では、腫瘍多重遺伝子検出キットの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 腫瘍多重遺伝子検出キットの概要 - 種類別分析（2018年vs2022年vs2029年）：可逆的終端シーケンス、半導体シーケンス、複合プローブアンカー重合シーケンス - 用途別分析（2018年vs2022年vs2029年）：コンパニオン診断、早期がん検診、創薬、その他 - 世界の腫瘍多重遺伝子検出キット市場規模・予測 - 世界の腫瘍多重遺伝子検出キット生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Roche Foundation Medicine、Illumina Inc.、Life Technologies Corporation、Thermo Fisher Scientific、Memorial Sloan Kettering、Novogene、Geneseeq、AmoyDx、Burning Rock Medicine、NantHealth、Personal Genome Diagnostics、GTH.O ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：可逆的終端シーケンス、半導体シーケンス、複合プローブアンカー重合シーケンス ・用途別分析2018年-2029年：コンパニオン診断、早期がん検診、創薬、その他 ・腫瘍多重遺伝子検出キットの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・腫瘍多重遺伝子検出キットのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・腫瘍多重遺伝子検出キットのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・腫瘍多重遺伝子検出キットの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・腫瘍多重遺伝子検出キットの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Tumor Multigene Detection Kit market size was valued at USD 902.4 million in 2022 and is forecast to a readjusted size of USD 2446.3 million by 2029 with a CAGR of 15.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Tumor NGS detection kit is an experimental consumable used in tumor detection
This report is a detailed and comprehensive analysis for global Tumor Multigene Detection Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Tumor Multigene Detection Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Tumor Multigene Detection Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Tumor Multigene Detection Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Tumor Multigene Detection Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tumor Multigene Detection Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global Tumor Multigene Detection Kit market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific and Memorial Sloan Kettering, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Tumor Multigene Detection Kit market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Reversible End Termination Sequencing
Semiconductor Sequencing
Combined Probe Anchored Polymerization Sequencing
Market segment by Application
Companion Diagnostics
Early Cancer Screening
Drug Discovery
Other
Major players covered
Roche Foundation Medicine
Illumina Inc.
Life Technologies Corporation
Thermo Fisher Scientific
Memorial Sloan Kettering
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
NantHealth
Personal Genome Diagnostics
GTH.O
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tumor Multigene Detection Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tumor Multigene Detection Kit, with price, sales, revenue and global market share of Tumor Multigene Detection Kit from 2018 to 2023.
Chapter 3, the Tumor Multigene Detection Kit competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tumor Multigene Detection Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Tumor Multigene Detection Kit market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tumor Multigene Detection Kit.
Chapter 14 and 15, to describe Tumor Multigene Detection Kit sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Tumor Multigene Detection Kit
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Tumor Multigene Detection Kit Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Reversible End Termination Sequencing
1.3.3 Semiconductor Sequencing
1.3.4 Combined Probe Anchored Polymerization Sequencing
1.4 Market Analysis by Application
1.4.1 Overview: Global Tumor Multigene Detection Kit Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Companion Diagnostics
1.4.3 Early Cancer Screening
1.4.4 Drug Discovery
1.4.5 Other
1.5 Global Tumor Multigene Detection Kit Market Size & Forecast
1.5.1 Global Tumor Multigene Detection Kit Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Tumor Multigene Detection Kit Sales Quantity (2018-2029)
1.5.3 Global Tumor Multigene Detection Kit Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Roche Foundation Medicine
2.1.1 Roche Foundation Medicine Details
2.1.2 Roche Foundation Medicine Major Business
2.1.3 Roche Foundation Medicine Tumor Multigene Detection Kit Product and Services
2.1.4 Roche Foundation Medicine Tumor Multigene Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Foundation Medicine Recent Developments/Updates
2.2 Illumina Inc.
2.2.1 Illumina Inc. Details
2.2.2 Illumina Inc. Major Business
2.2.3 Illumina Inc. Tumor Multigene Detection Kit Product and Services
2.2.4 Illumina Inc. Tumor Multigene Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Illumina Inc. Recent Developments/Updates
2.3 Life Technologies Corporation
2.3.1 Life Technologies Corporation Details
2.3.2 Life Technologies Corporation Major Business
2.3.3 Life Technologies Corporation Tumor Multigene Detection Kit Product and Services
2.3.4 Life Technologies Corporation Tumor Multigene Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Life Technologies Corporation Recent Developments/Updates
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Tumor Multigene Detection Kit Product and Services
2.4.4 Thermo Fisher Scientific Tumor Multigene Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments/Updates
2.5 Memorial Sloan Kettering
2.5.1 Memorial Sloan Kettering Details
2.5.2 Memorial Sloan Kettering Major Business
2.5.3 Memorial Sloan Kettering Tumor Multigene Detection Kit Product and Services
2.5.4 Memorial Sloan Kettering Tumor Multigene Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Memorial Sloan Kettering Recent Developments/Updates
2.6 Novogene
2.6.1 Novogene Details
2.6.2 Novogene Major Business
2.6.3 Novogene Tumor Multigene Detection Kit Product and Services
2.6.4 Novogene Tumor Multigene Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novogene Recent Developments/Updates
2.7 Geneseeq
2.7.1 Geneseeq Details
2.7.2 Geneseeq Major Business
2.7.3 Geneseeq Tumor Multigene Detection Kit Product and Services
2.7.4 Geneseeq Tumor Multigene Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Geneseeq Recent Developments/Updates
2.8 AmoyDx
2.8.1 AmoyDx Details
2.8.2 AmoyDx Major Business
2.8.3 AmoyDx Tumor Multigene Detection Kit Product and Services
2.8.4 AmoyDx Tumor Multigene Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AmoyDx Recent Developments/Updates
2.9 Burning Rock Medicine
2.9.1 Burning Rock Medicine Details
2.9.2 Burning Rock Medicine Major Business
2.9.3 Burning Rock Medicine Tumor Multigene Detection Kit Product and Services
2.9.4 Burning Rock Medicine Tumor Multigene Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Burning Rock Medicine Recent Developments/Updates
2.10 NantHealth
2.10.1 NantHealth Details
2.10.2 NantHealth Major Business
2.10.3 NantHealth Tumor Multigene Detection Kit Product and Services
2.10.4 NantHealth Tumor Multigene Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 NantHealth Recent Developments/Updates
2.11 Personal Genome Diagnostics
2.11.1 Personal Genome Diagnostics Details
2.11.2 Personal Genome Diagnostics Major Business
2.11.3 Personal Genome Diagnostics Tumor Multigene Detection Kit Product and Services
2.11.4 Personal Genome Diagnostics Tumor Multigene Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Personal Genome Diagnostics Recent Developments/Updates
2.12 GTH.O
2.12.1 GTH.O Details
2.12.2 GTH.O Major Business
2.12.3 GTH.O Tumor Multigene Detection Kit Product and Services
2.12.4 GTH.O Tumor Multigene Detection Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 GTH.O Recent Developments/Updates
3 Competitive Environment: Tumor Multigene Detection Kit by Manufacturer
3.1 Global Tumor Multigene Detection Kit Sales Quantity by Manufacturer (2018-2023)
3.2 Global Tumor Multigene Detection Kit Revenue by Manufacturer (2018-2023)
3.3 Global Tumor Multigene Detection Kit Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Tumor Multigene Detection Kit by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Tumor Multigene Detection Kit Manufacturer Market Share in 2022
3.4.2 Top 6 Tumor Multigene Detection Kit Manufacturer Market Share in 2022
3.5 Tumor Multigene Detection Kit Market: Overall Company Footprint Analysis
3.5.1 Tumor Multigene Detection Kit Market: Region Footprint
3.5.2 Tumor Multigene Detection Kit Market: Company Product Type Footprint
3.5.3 Tumor Multigene Detection Kit Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Tumor Multigene Detection Kit Market Size by Region
4.1.1 Global Tumor Multigene Detection Kit Sales Quantity by Region (2018-2029)
4.1.2 Global Tumor Multigene Detection Kit Consumption Value by Region (2018-2029)
4.1.3 Global Tumor Multigene Detection Kit Average Price by Region (2018-2029)
4.2 North America Tumor Multigene Detection Kit Consumption Value (2018-2029)
4.3 Europe Tumor Multigene Detection Kit Consumption Value (2018-2029)
4.4 Asia-Pacific Tumor Multigene Detection Kit Consumption Value (2018-2029)
4.5 South America Tumor Multigene Detection Kit Consumption Value (2018-2029)
4.6 Middle East and Africa Tumor Multigene Detection Kit Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Tumor Multigene Detection Kit Sales Quantity by Type (2018-2029)
5.2 Global Tumor Multigene Detection Kit Consumption Value by Type (2018-2029)
5.3 Global Tumor Multigene Detection Kit Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Tumor Multigene Detection Kit Sales Quantity by Application (2018-2029)
6.2 Global Tumor Multigene Detection Kit Consumption Value by Application (2018-2029)
6.3 Global Tumor Multigene Detection Kit Average Price by Application (2018-2029)
7 North America
7.1 North America Tumor Multigene Detection Kit Sales Quantity by Type (2018-2029)
7.2 North America Tumor Multigene Detection Kit Sales Quantity by Application (2018-2029)
7.3 North America Tumor Multigene Detection Kit Market Size by Country
7.3.1 North America Tumor Multigene Detection Kit Sales Quantity by Country (2018-2029)
7.3.2 North America Tumor Multigene Detection Kit Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Tumor Multigene Detection Kit Sales Quantity by Type (2018-2029)
8.2 Europe Tumor Multigene Detection Kit Sales Quantity by Application (2018-2029)
8.3 Europe Tumor Multigene Detection Kit Market Size by Country
8.3.1 Europe Tumor Multigene Detection Kit Sales Quantity by Country (2018-2029)
8.3.2 Europe Tumor Multigene Detection Kit Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Tumor Multigene Detection Kit Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Tumor Multigene Detection Kit Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Tumor Multigene Detection Kit Market Size by Region
9.3.1 Asia-Pacific Tumor Multigene Detection Kit Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Tumor Multigene Detection Kit Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Tumor Multigene Detection Kit Sales Quantity by Type (2018-2029)
10.2 South America Tumor Multigene Detection Kit Sales Quantity by Application (2018-2029)
10.3 South America Tumor Multigene Detection Kit Market Size by Country
10.3.1 South America Tumor Multigene Detection Kit Sales Quantity by Country (2018-2029)
10.3.2 South America Tumor Multigene Detection Kit Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Tumor Multigene Detection Kit Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Tumor Multigene Detection Kit Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Tumor Multigene Detection Kit Market Size by Country
11.3.1 Middle East & Africa Tumor Multigene Detection Kit Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Tumor Multigene Detection Kit Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Tumor Multigene Detection Kit Market Drivers
12.2 Tumor Multigene Detection Kit Market Restraints
12.3 Tumor Multigene Detection Kit Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Tumor Multigene Detection Kit and Key Manufacturers
13.2 Manufacturing Costs Percentage of Tumor Multigene Detection Kit
13.3 Tumor Multigene Detection Kit Production Process
13.4 Tumor Multigene Detection Kit Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Tumor Multigene Detection Kit Typical Distributors
14.3 Tumor Multigene Detection Kit Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer